Opportunities
Grants, VC funds, accelerators, and competitions for African entrepreneurs.
Grants, VC funds, accelerators, and competitions for African entrepreneurs.
What are you looking for today?
Powered by CopilotKit
$5M–$100M+
International organization hosted by WHO that invests in innovations to prevent, diagnose, and treat HIV/AIDS, TB, malaria, and other diseases in low- and middle-income countries. Major funder of health innovation in Africa with $52.5M SUPREME initiative announced March 2026 for maternal health across 7 African countries. Works through large implementing partners, not direct startup grants.
Large-Scale Grants
Multi-million dollar grants for health innovation implementation ($5M-$100M+)
Market Shaping
Support to make health products more affordable and accessible globally
SUPREME Initiative
$52.5M for maternal health (preeclampsia, anemia) across 7 African countries (March 2026)
Local Manufacturing
Support for regional health product manufacturing in Africa (e.g., lenacapavir in South Africa)
Large-scale health innovation projects with proven concept seeking transition to scale. Diagnostic and treatment innovations, market-shaping interventions, supply chain solutions. Primarily works with established international organizations (CHAI, Amref, Jhpiego, MSF).
Market shaping support, transition-to-scale planning, co-funding partnerships, WHO policy engagement
Not accessible for startups or small organizations. Grants go to large international health organizations in consortium. Very competitive, long decision timelines. Primarily for proven innovations seeking scale.
Unitaid is a market shaper, not a traditional grant funder. They invest in making health innovations affordable at scale. The SUPREME initiative ($52.5M, March 2026) shows their continued commitment to Africa. African health ministers are strengthening partnership with Unitaid for 'African sovereignty and innovation in health.' Best accessed through partnership with established implementers like CHAI, Amref, or Jhpiego.
2006
Active Since
Yes
Deploying
SUPREME initiative ($52.5M maternal health), lenacapavir local manufacturing in South Africa, $4B+ cumulative investment since 2006